Simplex Trading’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$134K Buy
+27,000
New +$131K ﹤0.01% 4756
2025
Q3
Sell
-4,200
Closed -$13K 9993
2025
Q2
$13K Sell
4,200
-3,900
-48% -$11.6K ﹤0.01% 7132
2025
Q1
$26K Buy
+8,100
New +$28.5K ﹤0.01% 6377
2024
Q3
Sell
-300
Closed -$1K 9511
2024
Q2
$1K Buy
+300
New +$1.46K ﹤0.01% 8563
2024
Q1
Sell
-4,000
Closed -$18K 9821
2023
Q4
$18K Buy
+4,000
New +$15K ﹤0.01% 7021

Other funds holding SOPH

Simplex Trading's SOPH Position: Q1 2026 in Review

Simplex Trading sold out of SOPHiA GENETICS (SOPH) in Q1 2026, closing a stake of 31 shares — an estimated $151 sold.

Simplex Trading first reported a position in SOPH in Q2 2023 and held it in 3 quarters. The position peaked at $4K in Q3 2025. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • Simplex Trading reported no remaining SOPHiA GENETICS position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 31 SOPHiA GENETICS shares in Q1 2026, an estimated $151.
  • Simplex Trading first reported a position in SOPHiA GENETICS in Q2 2023 and held it in 3 quarters.
  • Simplex Trading's SOPHiA GENETICS position peaked at $4K in Q3 2025.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.